Delivery Order SPE2DR25D3301-SPE2DR26F25BF

<p>The Defense Logistics Agency issued a delivery order to AmerisourceBergen Drug Corp on March 11, 2026, for barhemsys 10 mg/4 ml vial with a ceiling value of $1,232.66 and an ultimate completion date of March 12, 2026.</p> <p>Place of performance is Conshohocken, PA. The order carries firm fixed pricing and was issued under no set-aside.</p>

<p>The Defense Logistics Agency issued a $1,506.63 delivery order to Amerisourcebergen Drug Corp on March 23, 2026, for Barhemsys 10 mg/4 mL vial pharmaceutical product.</p> <p>Place of performance is Conshohocken, PA. The order carries a firm fixed price and ultimate completion date of March 24, 2026. The delivery order was issued under a non-competitive basis with no set-aside applied.</p>

<p>The Defense Logistics Agency issued a $1,093.35 delivery order to Amerisourcebergen Drug Corp on February 18, 2026, for Barhemsys 10 mg/4 ml vials.</p> <p>Place of performance is Conshohocken, PA. The order carries a firm fixed price and an ultimate completion date of February 19, 2026. No set-aside was used.</p>

<p>The Defense Logistics Agency issued a $1,402 delivery order to Amerisourcebergen Drug Corp on February 24, 2026, for Barhemsys 10 mg/4 ml vial (4 ml), with an ultimate completion date of February 25, 2026.</p> <p>Place of performance is Conshohocken, PA. The order is firm fixed price with no set-aside used.</p>

The Defense Logistics Agency issued a delivery order to AmerisourceBergen Drug Corp on March 31, 2026, for barhemsys 10 mg/4 ml vial (4 ml) with a firm fixed price ceiling of $1,191.16. Place of performance is Conshohocken, PA. The order has an ultimate completion date of April 1, 2026. No set-aside was used. The order was issued under the parent Indefinite Delivery Contract with DLA Troop Support Medical, a comprehensive global pharmaceutical support vehicle valued at up to $999,999,999.00...

<p>The Defense Logistics Agency issued a $6,130.01 delivery order to AmerisourceBergen Drug Corp on March 12, 2026, for Barhemsys 10 mg/4 ml vial pharmaceutical product.</p> <p>The order is issued under AmerisourceBergen's Indefinite Delivery Contract with DLA Troop Support Medical, valued at $999,999,999.00 and running through December 2026. Place of performance is Conshohocken, PA. The order has a firm fixed price structure with an ultimate completion date of March 13, 2026.</p>

The Defense Logistics Agency issued a $4,372.81 delivery order to Amerisourcebergen Drug Corp on March 4, 2026, for Barhemsys 10 mg/4 ml vial pharmaceutical product. Place of performance is Conshohocken, PA. Ultimate completion date is March 5, 2026. The order is priced on a firm fixed-price basis and carries no set-aside. This delivery order is issued against Amerisourcebergen Drug Corp's parent company Cencora, Inc., which holds a $999,999,999 indefinite delivery contract with DLA Troop...

<p>The Defense Logistics Agency issued a $1,205.49 delivery order to Amerisourcebergen Drug Corp on March 19, 2026, for BARHEMSYS 10 MG/4 ML vials.</p> <p>The order is issued under the DLA Troop Support Medical IDC (SPE2DX), a comprehensive global pharmaceutical supply vehicle valued at $999,999,999.00 and extending through December 2026. Place of performance is Conshohocken, PA. The order has a firm fixed price structure and an ultimate completion date of March 20, 2026.</p>

The Defense Logistics Agency awarded a $34,662.30 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 4,562 vials of Barhemsys (10 mg/4 ml). The place of performance will be Amerisourcebergen's facility in Conshohocken, Pennsylvania, with work occurring from September 12-13, 2023. Amerisourcebergen Corporation is the parent company of Amerisourcebergen Drug Corporation. No subcontractors or set aside designations were identified. The Defense Logistics Agency manages the...

The Defense Logistics Agency issued a $1,765.38 delivery order to Amerisourcebergen Drug Corp on March 5, 2026, for pharmaceutical supply (Barhemsys 5 mg/2 ml vial, 2 ml quantity). The order is issued under the DLA Troop Support Medical IDC, valued at up to $999,999,999 through December 2026, which serves as a comprehensive global pharmaceutical support vehicle enabling supply of pharmaceutical products and medical supplies to military healthcare programs worldwide. Place of performance is...